title: [Clinical immunological rationale of interferon therapy in chronic bacterial prostatitis].
abstract: The study of changes in the immune status of patients with chronic bacterial prostatitis demonstrated changes in immunological parameters reflecting depression of the immune system (subnormal levels of interferon alpha, gamma, sIgA, functional activity of neutrophils, high concentration of IgA, IgG, IgM). Thus, combined treatment of chronic bacterial prostatitis must include administration of immunomodulators.
authors.forename: A A
authors.initials: AA
authors.lastname: Kamalov
authors.forename: E A
authors.initials: EA
authors.lastname: Efremov
authors.forename: S D
authors.initials: SD
authors.lastname: Dorofeev
authors.forename: A A
authors.initials: AA
authors.lastname: Tret'iakov
authors.forename: D A
authors.initials: DA
authors.lastname: Okhobotov
authors.forename: Ia I
authors.initials: IaI
authors.lastname: Mel'nik
authors.forename: D A
authors.initials: DA
authors.lastname: Bedretdinova
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000097:blood; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D011472:Prostatitis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology* / Q000382:microbiology; D012720:Severity of Illness Index; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D016898:Interferon-alpha; D007371:Interferon-gamma